Liquid Biopsy Based NGS in Newly Diagnosed NSCLC (NCT05853887)
iNUDGE: INtegration of liqUiD Biopsy Based Next Generation Gene sEquencing in Newly Diagnosed NSCLC - A Stepped Wedge Cluster Randomized Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
This study expands the application of an electronic health record (EHR) "nudge" used to prompt physicians' clinical practice to order molecular testing at the time of initial diagnosis for patients with specific types of advanced lung cancer. The primary goal is to have these test results available prior to starting treatment so that physicians can make molecularly-informed treatment decisions. The second goal is to better understand factors that contribute to whether or not the EHR-nudge implementation is successful.
Who can join: Review the eligibility criteria below.
Location: Penn Medicine Cherry Hill — Cherry Hill, New Jersey
🧪 Interventions in This Study
- iNUDGE (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Penn Medicine Cherry Hill — Cherry Hill, New Jersey
- Penn Medicine Princeton Health — Plainsboro, New Jersey
- Penn Medicine Washington Township — Sewell, New Jersey
- Penn Medicine Voorhees — Voorhees Township, New Jersey
- Penn Medicine Lancaster General Health — Lancaster, Pennsylvania
- Penn Presbyterian Medical Center — Philadelphia, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Non Small Cell Lung Cancer Metastatic
- Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer — Santa Rosa, California
- Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma — London, Ontario
- A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain — Miami, Florida
Explore by condition: All Non Small Cell Lung Cancer Metastatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.